Is There Any Improvement of the Coagulation Imbalance in Sickle Cell Disease after Hematopoietic Stem Cell Transplantation?

Several components of the clotting system are modified towards hypercoagulability in sickle cell disease (SCD). To date, hematopoietic stem cell transplantation (HSCT) is the only validated curative treatment of SCD. Here, we investigated the changes in the hemostatic potential of SCD children who’v...

Descripción completa

Detalles Bibliográficos
Autores principales: Rozen, Laurence, Noubouossie, Denis F., Dedeken, Laurence, Lê, Phu Quoc, Ferster, Alina, Demulder, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912463/
https://www.ncbi.nlm.nih.gov/pubmed/31717804
http://dx.doi.org/10.3390/jcm8111796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912463/
https://www.ncbi.nlm.nih.gov/pubmed/31717804
http://dx.doi.org/10.3390/jcm8111796

Ejemplares similares